Haier Biomedical's Mobile PCR Testing Laboratory Contributes to the Fight Against the Pandemic with Improved Testing Capacity

COVID-19 cases have surged in Indonesia with the end of the long new year holidays and the spread of the Omicron variant.

As of March 11, Indonesia has reported 5.86 million confirmed cases cumulatively, including 5.33 million cases of patients cured and discharged from the hospital.

As public places featuring dense and complicated flow of people, airports are the main battlefield of preventing importation, spread, and exportation of the pandemic. According to Indonesia's pandemic prevention policies, all domestic airline passengers must have a negative PCR test certificate before traveling by air, and all incoming passengers must accept PCR nucleic acid testing again at the airports of entry. However, as the huge traffic requires a testing speed and quality that is far beyond the capability of the existing testing method, airports sustained enormous pressures, and passengers also suffered great travel inconvenience. To improve the speed and efficiency of nucleic acid testing, local airports of the Sumatra Island in Northern Indonesia introduced the Mobile PCR Nucleic Acid Testing Laboratory designed by Haier Biomedical.